Brief: Fischer Medical Ventures Confirms Collaboration With Nanyang Biologics
July 16 (Reuters) - Fischer Medical Ventures Ltd
FISC.BO :
* CONFIRMED ITS COLLABORATION WITH NANYANG BIOLOGICS
* FIRM UP MARKETING RIGHTS OF NANYANG BIOLOGICS
TRANSFORMATIVE
NUTRACEUTICALS
* MARKETING RIGHTS FOR INDIA, MIDDLE EAST & ASEAN REGION
Source text for Eikon: ID:nBSE99604M
Further company coverage: FISC.BO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Fischer Medical Ventures
See all newsBrief: Fischer Medical Ventures Approves Investment In Fischer Hospitality
Brief: Fischer Medical Ventures To Supply 10 1.5T Whole Body Mri Machines To Atrium Diagnostics
Brief: Fischer Medical Ventures Unit Launches Sikkim MRI PPP Project For Tuberculosis Diagnostic Screening
Brief: Fischer Medical Ventures Says Unit Got License To Manufacture MRI By CDSCO
Brief: Fischer Medical Ventures Withdraws Proposed Preferential Issue Announced On August 14, 2024